62
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Serum growth factors in asbestosis patients

, , , , , & show all
Pages 61-66 | Received 30 Oct 2008, Accepted 09 Dec 2008, Published online: 01 Feb 2009

References

  • Auscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL.1993. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592–1598.
  • Becklake MR, Bagatin E, Neder JA.2007. Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis 11:356–369.
  • Border WA, Noble NA.1994. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292.
  • Brandt-Rauf PW, Smith S, Hemminki K, Koskinen H, Vainio H, Niman H, Ford J.1992. Serum oncoproteins and growth factors in asbestosis and silicosis patients. Int J Cancer 50:881–885.
  • Brody AR.1993. Asbestos-induced lung disease. Environ Health Perspect 100:21–30.
  • Brody AR.1997. Occupational lung disease and the role of peptide growth factors. Curr Opin Pulm Med 3:203–208.
  • Broekelman TJ, Limper AH, Colby TV, MacDonald JA.1991. Transforming growth factor-β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88:6642–6646.
  • DiGiovine B, Lynch JP, Martinez FL.1996. The presence of pro-fibrotic cytokines correlate with outcome in patients with idiopathic pulmonary fibrosis. Chest 109:24S.
  • DiMari SJ, Howe AM, Haralson MA.1991. Effects of transforming growth factor-β on collagen synthesis by fetal rat lung epithelial cells. Am J Respir Cell Mol Biol 4:455–462.
  • Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJ, Angel P, Heath JK.1987. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 7:1899–1904.
  • Ford J, Smith S, Luo JC, Friedman-Jimenez G, Brandt-Rauf P, Markowitz S, Garabaldi K, Niman H.1992. Serum growth factors and oncoproteins in firefighters. Occup Med (Lond) 42:39–42.
  • Gharaee-Kermani M, Denholm EM, Phan SH.1996. Costimulation of fibroblast collagen and transforming growth factor beta 1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271:12229–12284.
  • Husgafvel-Pursiainen K, Kannio A, Oksa P, Suitiala T, Koskinen H, Hemminki K, Smith S, Rosenstock-Leibu R, Brandt-Rauf PW.1997. Mutations, tissue accumulations and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure. Environ Mol Mutagen 30:224–230.
  • Ignotz RA, Massague J.1986. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J Biol Chem 261:4337–4345.
  • Jagirdar J, Begin R, Dufresne A, Goswami S, Lee TC, Rom WN.1996. Transforming growth factor β in silicosis. Am J Respir Crit Care Med 154:1844–1847.
  • Jagirdar J, Lee TC, Reibman J, Gold LI, Aston C, Begin R, Rom WN.1997. Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Perspect 105:1197–1203.
  • Khalil N, O’Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH.1991. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5:155–162.
  • Lee TC, Gold LI, Reibman J, Aston C, Begin R, Rom WN, Jagirdar J. 1997. Immunohistochemical localization of transforming growth factor-β and insulin-like growth factor-I in asbestosis in the sheep model. Int Arch Occup Environ Health 69:157–164.
  • Li Y, Karjalainen A, Koskinen H, Hemminki K, Vainio H, Shnaidman M, Ying Z, Pukkala E, Brandt-Rauf PW.2005. p53 autoantibodies predict subsequent development of cancer. Int J Cancer 114:157–160.
  • Lin RT, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T, Chen CC, Wen CP, Furuya S, Higashi T, Chien LC, Ohtaki M.2007. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet 369:844–849.
  • Liu JY, Brody AR.2001. Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice. J Environ Pathol Toxicol Oncol 20:97–108.
  • Maniscalo WM, Campbell MH.1994. Transforming growth factor-beta induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells. Am J Physiol 266:L672–L680.
  • Mariani TJ, Roby JD, Mecham RP, Parks WC, Crouch E, Pierce RA. 1996. Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor-beta as a mediator of fibrosis. Am J Pathol 148:151–164.
  • Massague J, Chiefitz S, Laiho M, Ralph DA, Weis FMB, Zentella A. 1992. Transforming growth factor-β. Cancer Surv 12:81–103.
  • Mossman BT, Kamp DW, Weitzman SA.1996. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancer. Cancer Invest 14:466–480.
  • Oksa P, Pukkala E, Karjalainen A, Ojajarvi A, Huuskonen MS.1997. Cancer incidence and mortality among Finnish asbestos sprayers and in asbestosis and silicosis patients. Am J Ind Med 31:693–698.
  • Oksa P.1998. Asbestosis, Its Detection, and Predictors of Progression and Cancer. Helsinki: Finnish Institute of Occupational Health.
  • O’Reilly KMA, McLaughlin AM, Beckett WS, Sime PJ.2007. Asbestos-related lung disease. Am Fam Physician 75:683–688.
  • Partanen R, Hemminki K, Koskinen H, Luo JC, Carney WP, Brandt-Rauf PW.1994. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients. J Occup Med 36:1324–1328.
  • Perdue TD, Brody AR.1994. Distribution of transforming growth factor-beta 1, fibronectin, and smooth muscle actin in asbestos-induced pulmonary fibrosis in rats. J Histochem Cytochem 42;1061–1070.
  • Polyak K.1996. Negative regulation of cell growth by TGF beta. Biochim Biophys Acta 1242:185–189.
  • Robledo R, Mossman B.1999. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cellular Physiol 180:158–166.
  • Teppo L, Pukkala E, Lehtonen M.1994. Data quality and quality control of a population-based cancer registry. Acta Oncol 33:365–369.
  • Vanhee D, Gosset P, Wallaert B, Voisin C, Tonnel AB.1994. Mechanisms of fibrosis in coal workers’ pneumoconiosis: increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity: clinical relevance of cellular mediators of inflammation in workers exposed to asbestos. Am J Respir Crit Care Med 150:881–885.
  • Yao W, Feng FF, Jiao J, Wang N.2006. Expression level and significance of TGF-beta1, PDGF, CTGF in serum of patients with pneumoconiosis. Sichuan Da Xue Xue Bao Yi Xue Ban 37:754–756.
  • Yoshida M, Sakuma J, Hayashi S, Abe K, Saito I, Harada S, Sakatani M, Yamamoto S, Matsumoto N, Kaneda Y, Kishimoto T.1995. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet derived growth factor B gene. Proc Natl Acad Sci USA 92:9570–9574.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.